Litcius/Paper detail

Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study

Lisanne M. Baak, Nienke Wagenaar, Niek E. van der Aa, Floris Groenendaal, Jeroen Dudink, Maria Luisa Tataranno, Ubah Mahamuud, Cornelia H. Verhage, Rian M. J. C. Eijsermans, Liesbeth S. Smit, Reint K. Jellema, Timo R. de Haan, Hendrik J. ter Horst, Willem P. de Boode, Sylke J. Steggerda, Henk‐Jan Prins, Colin de Haar, Linda S. de Vries, Frank van Bel, Cobi J. Heijnen, Cora H. Nijboer, Manon J.N.L. Benders

2022The Lancet Neurology161 citationsDOIOpen Access PDF

Topics & Concepts

Mesenchymal stem cellMedicineNasal administrationIntervention (counseling)Stroke (engine)PassionStromal cellIschaemic strokeInternal medicinePathologyIschemiaImmunologyPsychologyPsychiatryEngineeringPsychotherapistMechanical engineeringMesenchymal stem cell researchNeonatal and fetal brain pathologyMoyamoya disease diagnosis and treatment